Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Sandborn, 2002, A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease, Gastroenterology, 122, 512, 10.1053/gast.2002.31072

Best, 1976, Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study, Gastroenterology, 70, 439, 10.1016/S0016-5085(76)80163-1

Harvey, 1980, A simple index of Crohn's-disease activity, Lancet, 1, 514, 10.1016/S0140-6736(80)92767-1

Thia, 1002, Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index, Inflamm Bowel Dis, 17, 105, 10.1002/ibd.21400

Andre, 1981, Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index, Gut, 22, 571, 10.1136/gut.22.7.571

Cellier, 1994, Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases, GUT, 35, 231, 10.1136/gut.35.2.231

Modigliani, 1990, Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Gastroenterology, 98, 811, 10.1016/0016-5085(90)90002-I

Rutgeerts, 2006, Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease, Gastrointest Endosc, 63, 433, 10.1016/j.gie.2005.08.011

Colombel, 1383, Infliximab, azathioprine, or combination therapy for Crohn's disease, N Engl J Med, 362, 1383, 10.1056/NEJMoa0904492

Bouguen, 2011, Surgery for adult Crohn's disease: what is the actual risk?, Gut, 60, 1178, 10.1136/gut.2010.234617

Peyrin-Biroulet, 2011, Results from the 2nd Scientific Workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease, J Crohns Colitis, 5, 477, 10.1016/j.crohns.2011.06.009

Rutgeerts, 2012, Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial, Gastroenterology, 142, 1102, 10.1053/j.gastro.2012.01.035

Solem, 2005, Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease, Inflamm Bowel Dis, 11, 707, 10.1097/01.MIB.0000173271.18319.53

Baars, 1002, Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation, Inflamm Bowel Dis, 2011, 21925

Samuel, 2012, Endoscopic skipping of the distal terminal ileum in crohn's disease can lead to negative results from ileocolonoscopy, Clin Gastroenterol Hepatol, 10, 1253, 10.1016/j.cgh.2012.03.026

Ferrante, 2011, Evolution of endoscopic activity scores in patients with crohn's disease under azathioprine and/or infliximab: a post-hoc analysis of the sonic data, Gastroenterology, 140, S422, 10.1016/S0016-5085(11)61734-4